Furthermore, elevated nuclear FOXO3 levels may suppress the transcription of critical cuproptosis-related genes, such as FDX1, thereby impairing copper-induced cell death and fostering chemotherapy resistance in tumor cells. Here, FDX1 is linked to neoplasm.